KEGG   PATHWAY: vpc04940
Entry
vpc04940                    Pathway                                
Name
Type I diabetes mellitus - Vicugna pacos (alpaca)
Description
Type I diabetes mellitus is a disease that results from autoimmune destruction of the insulin-producing beta-cells. Certain beta-cell proteins act as autoantigens after being processed by antigen-presenting cell (APC), such as macrophages and dendritic cells, and presented in a complex with MHC-II molecules on the surface of the APC. Then immunogenic signals from APC activate CD4+ T cells, predominantly of the Th1 subset. Antigen-activated Th1 cells produce IL-2 and IFNgamma. They activate macrophages and cytotoxic CD8+ T cells, and these effector cells may kill islet beta-cells by one or both of two types of mechanisms: (1) direct interactions of antigen-specific cytotoxic T cells with a beta-cell autoantigen-MHC-I complex on the beta-cell, and (2) non-specific inflammatory mediators, such as free radicals/oxidants and cytokines (IL-1, TNFalpha, TNFbeta, IFNgamma).
Type I diabetes is a polygenic disease. One of the principle determining genetic factors in diabetes incidence is the inheritance of mutant MHC-II alleles. Another plausible candidate gene is the insulin gene.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
vpc04940  Type I diabetes mellitus
vpc04940

Organism
Vicugna pacos (alpaca) [GN:vpc]
Gene
116285510  INS; insulin [KO:K04526]
102538853  glutamate decarboxylase 1-like [KO:K01580] [EC:4.1.1.15]
102542714  GAD2; glutamate decarboxylase 2 [KO:K01580] [EC:4.1.1.15]
102534135  GAD1; glutamate decarboxylase 1 [KO:K01580] [EC:4.1.1.15]
102530462  PTPRN; receptor-type tyrosine-protein phosphatase-like N isoform X6 [KO:K07817] [EC:3.1.3.48]
116279547  receptor-type tyrosine-protein phosphatase N2-like [KO:K07817] [EC:3.1.3.48]
102528459  CPE; carboxypeptidase E [KO:K01294] [EC:3.4.17.10]
102539213  HSPD1; 60 kDa heat shock protein, mitochondrial [KO:K04077] [EC:5.6.1.7]
102529579  ICA1; islet cell autoantigen 1 isoform X4 [KO:K19863]
102532423  LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DP alpha 1 chain [KO:K06752]
102535226  HLA class II histocompatibility antigen, DO beta chain-like [KO:K06752]
102537458  LOW QUALITY PROTEIN: SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like [KO:K06752]
116284686  DLA class II histocompatibility antigen, DR-1 beta chain-like [KO:K06752]
102533644  rano class II histocompatibility antigen, A beta chain-like [KO:K06752]
102536963  mamu class II histocompatibility antigen, DR alpha chain [KO:K06752]
102537705  DLA class II histocompatibility antigen, DR-1 beta chain-like [KO:K06752]
102534820  SLA class II histocompatibility antigen, DQ haplotype D alpha chain [KO:K06752]
102532668  HLA class II histocompatibility antigen, DO alpha chain [KO:K06752]
102532908  HLA class II histocompatibility antigen, DM alpha chain isoform X2 [KO:K06752]
102533164  HLA class II histocompatibility antigen, DM beta chain [KO:K06752]
102538175  CD80; T-lymphocyte activation antigen CD80 isoform X1 [KO:K05412]
102527964  CD86; T-lymphocyte activation antigen CD86 isoform X1 [KO:K05413]
102526286  CD28; T-cell-specific surface glycoprotein CD28 [KO:K06470]
102530946  IL12A; interleukin-12 subunit alpha [KO:K05406]
102543998  IL12B; interleukin-12 subunit beta [KO:K05425]
102532988  IL2; interleukin-2 [KO:K05429]
102534412  IFNG; interferon gamma [KO:K04687]
102541118  LOW QUALITY PROTEIN: H-2 class I histocompatibility antigen, Q9 alpha chain-like [KO:K06751]
102541374  patr class I histocompatibility antigen, A-126 alpha chain-like isoform X1 [KO:K06751]
102541718  patr class I histocompatibility antigen, B-2 alpha chain-like isoform X1 [KO:K06751]
102531552  BOLA class I histocompatibility antigen, alpha chain BL3-7-like [KO:K06751]
102542278  LOW QUALITY PROTEIN: class I histocompatibility antigen, Gogo-B*0102 alpha chain-like [KO:K06751]
102542512  LOW QUALITY PROTEIN: popy Class I histocompatibility antigen, A-1 alpha chain-like [KO:K06751]
102545865  saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751]
102543520  BOLA class I histocompatibility antigen, alpha chain BL3-7-like isoform X1 [KO:K06751]
102545610  LOW QUALITY PROTEIN: class I histocompatibility antigen, Gogo-C*0203 alpha chain-like [KO:K06751]
116278047  uncharacterized protein LOC116278047 [KO:K10784]
116280840  LOW QUALITY PROTEIN: uncharacterized protein LOC116280840 [KO:K10784]
102536116  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
102535267  FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
102535945  PRF1; LOW QUALITY PROTEIN: perforin-1 [KO:K07818]
102535495  LOW QUALITY PROTEIN: mast cell protease 3-like [KO:K01353] [EC:3.4.21.79]
102532683  mast cell protease 1A-like [KO:K01353] [EC:3.4.21.79]
102545567  LOW QUALITY PROTEIN: granzyme B [KO:K01353] [EC:3.4.21.79]
102541673  LTA; lymphotoxin-alpha [KO:K05468]
102541924  TNF; tumor necrosis factor [KO:K03156]
102529843  IL1A; interleukin-1 alpha [KO:K04383]
102529565  IL1B; interleukin-1 beta [KO:K04519]
Compound
C00027  Hydrogen peroxide
C00533  Nitric oxide
C00704  Superoxide
Reference
PMID:9719467
  Authors
Rabinovitch A, Suarez-Pinzon WL.
  Title
Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.
  Journal
Biochem Pharmacol 55:1139-49 (1998)
DOI:10.1016/S0006-2952(97)00492-9
Reference
  Authors
Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, Todd JA, Concannon P
  Title
Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.
  Journal
Am J Hum Genet 69:820-30 (2001)
DOI:10.1086/323501
Reference
PMID:8072542
  Authors
Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, et al.
  Title
A genome-wide search for human type 1 diabetes susceptibility genes.
  Journal
Nature 371:130-6 (1994)
DOI:10.1038/371130a0
Reference
PMID:8786033
  Authors
Fujisawa T, Ikegami H, Kawaguchi Y, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Shima K, Ogihara T.
  Title
Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.
  Journal
Diabetologia 38:1493-5 (1995)
DOI:10.1007/BF00400620
Reference
  Authors
Jaeckel E, Klein L, Martin-Orozco N, von Boehmer H.
  Title
Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.
  Journal
J Exp Med 197:1635-44 (2003)
DOI:10.1084/jem.20030215
Reference
  Authors
Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS.
  Title
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
  Journal
Nature 435:220-3 (2005)
DOI:10.1038/nature03523
Reference
  Authors
Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA.
  Title
Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.
  Journal
Nature 435:224-8 (2005)
DOI:10.1038/nature03625
Reference
  Authors
Lieberman SM, DiLorenzo TP.
  Title
A comprehensive guide to antibody and T-cell responses in type 1 diabetes.
  Journal
Tissue Antigens 62:359-77 (2003)
DOI:10.1034/j.1399-0039.2003.00152.x
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Related
pathway
vpc04210  Apoptosis
vpc04660  T cell receptor signaling pathway
KO pathway
ko04940   
LinkDB

DBGET integrated database retrieval system